Hematopoietic stem cell transplantation
Health Related Quality of Life in leukemia Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced Intensity Conditioning
... Be that as it may, in conclusion, we have found that al- lografted individuals employing the Mexican RIC regimen after 12 months enjoy a health-related QOL similar to that of reference subjects, with this being another ...
8
Influence of a moderate-intensity exercise program on early nk cell immune recovery in pediatric patients after reduced-intensity hematopoietic stem cell transplantation
... The primary finding was that a moderate-intensity EP increases the mean ratio of CD56 dim cells and NKCC in immune-compromised children who receive allogeneic HSCT ≤30 days before starting EP intervention. It has been ...
9
Advantages of non cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy
... autologous transplantation were developed without cryopreservation [27 – ...healthy hematopoietic stem cells without exposi- tion to chemotherapy, making a widespread use of DMSO in regular practice ...
7
El programa de trasplantes de clulas hematopoyticas de la Clnica Ruiz de Puebla (1993 2016)
... 91. Ruiz-Delgado GJ, Lutz-Presno JA, Alarcón-Urdaneta C, Calderón-García J, Ruiz-Argüelles GJ. Body mass index as an indicator of prognosis in patients undergoing allogeneic hematopoietic stem cell ...
9
Efecto de autoinjerto contra tumor
... tologous hematopoietic stem cell transplantation for multiple ...blood stem cell graft positively correlate with event free survival of multiple myeloma ...
6
Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.
... The treatment of steroid-refractory acute graft-versus-host disease (aGVHD) remains a clinical challenge, for which no standard therapy exists. Alemtuzumab is a humanized anti-CD52 monoclonal antibody (mAb) that has been ...
6
A mathematical model of multistage hematopoietic cell lineages
... In section 2, we describe the biological background leading to an age-structured model of hematopoiesis. We obtain a system of eleven age-structured partial differential equations com- pleted by boundary and nonnegative ...
25
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
... after transplantation, 91% of patients in the ATG group but only 39% of those in the non- ATG group had discontinued immunosuppres- sive medication with ...
11
Trasplante doble en una paciente con mieloma mltiple: mdula sea y rin
... with stem cell transplantation and follow-up the patient to seek for renal function ...nal transplantation that achieved a better renal function with no ...
5
Trasplante de clulas hematopoyticas en mieloma mltiple
... blood stem cell support can be applied safely in these patients and achieves significantly higher complete remission rates as well as better event-free survival and overall ...tandem transplantation ...
9
Vol. 91, Núm. 4 (2020)
... A descriptive statistical analysis was made for all va- riables considered, dividing patients into two groups: ABMF and CBMF. The categorical variables are sum- marized in proportions and the continuous ones are ...
8
Characterization of Adult Stem/Progenitor Cell Populations From Bone Marrow in a Three-Dimensional Collagen Gel Culture System.
... Stem cell transplantation therapy using mesenchymal stem cells (MSCs) is considered a useful ...of stem and/or osteoprogenitor cells that are removed from primary culture dur- ing media ...
12
Liver transplantation followed by autologous stem cell transplantation for acute liver failure caused by AL amyloidosis Case report and review of the literature
... The patient was wait listed for a highly urgent liver transplant, which took place three days later. On patholog- ical examination, the explanted liver showed a massive perisinusoidal and vascular amyloidosis with ...
6
Trasplante de la vastago celula de Hematopoietic usando las clulas de sangre de la umbilical cuerda
... ver, the pattern and type of infectious complications in recipients of UCB transplants has not been stu- died in detail or in larger series of patients. A large survey by the Eurocord group is currently addres- sing this ...
10
Recuperacin temprana de linfocitos como factor pronstico en el trasplante hematopoytico
... 12. Joao C, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, et al. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell ...
10
Tratamiento de la leucemia mieloide crnica: 20 aos de experiencia en una sola institucin
... Alfa-interferon (IFN): 5,000,000 IU/day, subcu- taneously. It was associated with hydroxyurea according to the above-mentioned dosage. Hemopoietic stem cell transplant (HSCT): In all cases from a related ...
10
Stem Cell Biobanks for Research
... using stem cell derived medicinal products as therapeu- tics (Goldring et ...of stem cell based therapies today is the grafting of hematopoietic pro- genitors from the bone marrow (in ...
16
Estudio de los progenitores hematopoyéticos en el trasplante autogénico en pacientes con carcinoma de mama. Study of the hematopoietic progenitors in patients with breast cancer undergoing autologous peripheral blood stem cell transplantation
... En nuestro grupo de pacientes, ni la radioterapia o quimioterapia previas, ni el estadio tumoral, ni la movilización con fílgrastim o lenograstim, o la edad de las enfermas afectaron la velocidad del implante ...
200
Busulfan based myeloablative conditioning regimens for haploidentical transplantation in high risk acute leukemias and myelodysplastic syndromes
... We retrospectively reviewed 65 adult patients (Table 1) with AL or MDS who underwent HAPLO-MAC and for whom results were sent to the Haploidentical Transplantation Subcommittee of the Spanish Group for ...
27
Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemia.
... A cell lacking the MLL rearrangement show a two orange/green (yellow) fusion signal ...a cell possessing a MLL translocation, the expected pattern is one green/orange (yellow) fusion signal, one or- ange ...
5
